UK: 10 Things You Need To Know About The European Market Infrastructure Regulation

Last Updated: 18 September 2013
Article by Adrian Brown and Sam Robinson

Summary and implications

We have been talking about the European Market Infrastructure Regulation (EMIR) for years. With certain parts of EMIR now in force and others planned imminently, here are 10 key questions to help you understand if, and how, you will be affected by EMIR.

1. Should I care about EMIR?

Generally, if you are based in the European Economic Area and trade in derivatives, whether on-exchange or "over-the-counter" (OTC), then you will be impacted by EMIR. This could include real estate investors who use derivatives and swaps (e.g. hedging interest rate and currency risks) to reduce risk rather than for speculative purposes. The exact impact of EMIR will depend on the type of firm, as well as the level and type of derivative exposure of the particular firm.

2. What are the requirements under EMIR?

In summary, EMIR brings in new requirements relating to:

  • authorisation and supervision of central counterparties (CCPs) and trade repositories (TRs);
  • reporting trade details of all derivative trades (not just OTC) to TRs;
  • clearing "eligible" OTC derivatives through a CCP; and
  • when OTC derivatives are not centrally cleared, firms will need to implement alternative risk mitigation techniques.

While only a handful of firms are expected to become CCPs or TRs, other firms will need to consider how to comply with the requirements relating to clearing and trade reporting.

3. How do I satisfy the reporting requirement?

EMIR requires certain details of all derivatives (both OTC and on-exchange) to be reported to a TR by both counterparties.

From a practical perspective, once a TR has been registered to receive reporting information in relation to the type of derivative concerned, a firm must either:

1. enter into direct arrangements with a TR; or

2. delegate reporting arrangements to a third party (such as a broker, CCP or trading platform), which would in turn have an arrangement with a TR.

4. How will clearing work?

The European Securities and Markets Authority (ESMA), along with national regulators, will determine which "standard" OTC derivatives should be cleared through a CCP. They will take into account criteria including whether the derivatives have common legal documentation, volume, liquidity and the availability of fair, reliable and generally accepted pricing information. In July 2013 ESMA published a discussion paper outlining this procedure in further detail. When these derivatives have been determined and CCPs have been authorised, firms will then need to enter into either direct or indirect clearing arrangements with a CCP to clear these derivatives.

5. What about trades that are not centrally cleared?

OTC derivatives that are not cleared through a CCP can continue to be traded directly between counterparties. However, firms will need to comply with alternative risk mitigation techniques when entering into these types of OTC derivative contracts.

6. I've heard that EMIR applies differently to "financial counterparties" and "non-financial counterparties", is this correct?

This distinction is relevant in relation to the clearing and risk mitigation obligations. It does not make any difference to the trade reporting obligation.

The requirement to clear certain OTC derivatives through a CCP applies automatically to financial counterparties. However, this only applies to non-financial counterparties when they have exposure to OTC derivatives above a certain level, referred to as being a "NFC+".

In relation to the risk mitigation techniques, non-financial counterparties that do not exceed this level, referred to as being "NFC-", will only have to comply with some of the risk mitigation requirements (not all of them). Firms will need to consider whether they are a financial counterparty or a non-financial counterparty, and whether they are an NFC+ or NFC-, in relation to which clearing and risk mitigation obligations apply to them.

7. What are the thresholds between an NFC+ and an NFC-?

Non-financial counterparties will need to consider whether they have exposure to OTC derivatives above the thresholds in the table opposite. When making this calculation, firms are not required to take into account any OTC derivatives that they enter into for hedging purposes. But they must include all OTC derivatives entered into by non-financial counterparties within their group on a global basis. If a non-financial counterparty exceeds the clearing threshold they must notify the Financial Conduct Authority and ESMA.

8. What will firms need to do to satisfy the collateral requirement?

One of the risk mitigation requirements for OTC derivatives that are not cleared through a CCP relates to the exchange of collateral. While there has been much debate at international level, earlier this month the International Organisation of Securities Commissions and the Basel Committee on Banking Supervision published the final framework relating to the exchange of collateral. This confirmed, amongst other things, that parties will be required to exchange both initial and variation margin. These requirements will be implemented in the EU through new binding technical standards which will be consulted on by the European Banking Authority (co-operating with the other European regulators) in due course.

Impact on real estate

For a real estate sector business which is caught by EMIR:

  • standardised swap activities (determined by ESMA) may need to be cleared through CCPs, with appropriate liquid collateral (real estate does not currently count) and reporting; and
  • for swaps that are not cleared through a CCP, it will have to have risk management procedures in place, potentially including the marking-to-market of outstanding contracts on a daily basis.

9. What is the timing of EMIR?

EMIR enters into force on a staged basis. One of the risk mitigation techniques, relating to timely confirmation, entered into force on 15 March 2013. The risk mitigation techniques of portfolio reconciliation, portfolio compression and dispute resolution are scheduled to enter into force on 15 September 2013. The risk mitigation technique relating to the exchange of collateral is not expected to enter into force until 2014 or 2015.

The reporting obligation for credit and interest rate derivatives was scheduled to begin in September 2013, but ESMA recently announced that this has been delayed until 1 January 2014. This is the date from which the reporting obligations relating to the other types of derivatives should also apply. However, this date is dependent on the registration of a TR to accept the relevant trade reports.

With no CCPs having yet been authorised, the clearing obligation is not expected to come into force until 2014 or 2015.

10.How does EMIR fit in with the Alternative Investment Fund Managers Directive (AIFMD)?

EMIR applies differently depending on whether the relevant fund, or structuring entity that enters into OTC derivatives, is classified as an "alternative investment fund" (AIF) under the AIFMD.

AIFs fall within the definition of a financial counterparty. As mentioned above in question 6, this means that the full clearing and risk mitigation obligations would apply when an AIF enters into OTC derivatives (even for hedging purposes).

One important area is who is a "financial counterparty" and therefore within the scope of the more detailed requirements of EMIR. This includes AIFs under AIFMD, as well as banks and other financial institutions

However, any entity in a fund structure that is not an AIF will instead be classified as a non-financial counterparty (including a fund before it is classified as an AIF under the AIFMD). Where these entities enter into OTC derivatives, they will not need to comply with the full clearing and risk mitigation requirements unless they enter into OTC derivatives with a value above the relevant clearing threshold and become an NFC+. As mentioned in question 7, any calculation relating to whether a non-financial counterparty exceeds the clearing threshold would not take into account any OTC derivatives that have been entered into for hedging purposes.

This article was previously published by Compliance Complete by Thomson Reuters Accelus

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Mondaq Sign Up
Gain free access to lawyers expertise from more than 250 countries.
 
Email Address
Company Name
Password
Confirm Password
Position
Industry
Mondaq Newsalert
Select Topics
Select Regions
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions